Production and characterization of novel murine monoclonal antibodies against programmed death-ligand 1 with potential diagnostic application in immunohistochemistry

Puntos clave

• Monoclonal antibodies show promise in targeting programmed death-ligand 1 for diagnostic purposes, enhancing cancer detection.
• The study demonstrates efficient production and characterization of these antibodies using murine models.
• Assessment using immunohistochemistry reveals effective binding and activity of the antibodies against tissue samples.
• Potential clinical applications may improve diagnostic accuracy, prompting further research in cancer immunotherapy.